Development of a positron emission tomography radiopharmaceutical for imaging thymidine kinase gene expression: Synthesis and in vitro evaluation of 9-{(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl{guanine

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 14, 1997, Pages 1879-1882

  Monclus, Michel ^a   Luxen, André ^b   Cool, Vincent ^a   Damhaut, Philippe ^a   Velu, Thierry ^a   Goldman, Serge ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

9 [(3 FLUORO 2 HYDROXY 2 PROPOXY)METHYL]GUANINE; ACICLOVIR; ANTIVIRUS AGENT; FLUORINE 18; GANCICLOVIR; THYMIDINE KINASE; TRACER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DRUG DEVELOPMENT; DRUG PURIFICATION; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; ISOTOPE LABELING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT;

EID: 0030739708     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00325-9     Document Type: Article

References (17)

1. Culver, K. W.; Ram, Z.; Wallbridge, S.; Ishii, H.; Oldfield, E. H.; Blaese, R. M. Science 1992, 256, 1550.
2. Tjuvajev, J. G.; Stockhammer, G.; Desai, R.; Uehara, H.; Watanabe, K.; Gansbacher, B.; Blasberg, R. G. Cancer Res. 1995, 55, 6126.
3. Tjuvajev, J. G.; Finn R.; Watanabe, K.; Joshi, R.; Oku, T.; Kennedy, J.; Beattie, B.; Koutcher, J.; Larson, S.; Blasberg, R. Cancer Res. 1996, 56, 4087.
4. Barrio, J. R.; Namavari, M.; Phelps, M. E.; Satyamurthy, N. J. Org. Chem. 1996, 61, 6084.
5. Monclus, M.; Luxen, A.; Van Naemen, J.; Damhaut, P.; Velu, T.; Cool, V.; Goldman, S. J Labelled Compd Radiopharm 1995, 37, 193.
6. Alauddin, M. M.; Conti, P. S.; Mazza, S. M.; Hamzeh, F. M.; Lever, J. R. Nuclear Medecine & Biology 1996, 23, 787.
7. Martin, J. C.; McGee, D. P. C.; Jeffry, G. A.; Hobbs, D. W.; Smee, D. F.; Matthews, T. R.; Verheyden, J. P. H. J. Med. Chem. 1986, 29, 1384.
8. +: 564
9. Guillaume, M.; Luxen, A.; Nebeling, B.; Argentini, M.; Clark, J. C.; Pike, V. W. Appl. Radiat. Isot. 1991, 42, 749.
10. Cool, V.; Pirotte, B.; Gérard, C.; Dargent, J.-L.; Baudson, N.; Levivier, M.; Goldman, S.; Hildebrand, J.; Brotchi, J.; Velu, T. Hum. Gen. Ther. 1996, 7, 627.
11. Ashton, W. T.; Canning, L. F.; Reynolds, G. F.; Tolman, R. L.; Karkas, J. D.; Liou, R.; Davies, M.-E. M.; DeWitt, C. M.; Perry, H. C.; Field, A. K. J. Med. Chem. 1985, 28, 926.
12. Karkas, J. D.; Germershausen, J.; Tolman, R. L.; MacCoss, M.; Wagner, A. F.; Liou, R.; Bostedor, R. Biochim. Biophys. Acta 1987, 911, 127.
13. Kohlbrenner, W. E.; Carter, C. D.; Fesik, S. W.; Norbeck, D. W.; Erickson, J. Biochem. Pharmacol. 1990, 40, R5.
14. Synthesis of R and S enantiomers of FHPG. M. Monclus. Unpublished data.
15. Elion, G. B.; Furman, P. A.; Fyfe, J. A.; de Miranda, P.; Beauchamp, L.; Schaeffer, H. Proc. Natl. Acad. Sci. USA 1977, 74, 5716.
16. An authentic sample of FHPG monophosphate was prepared by treating N-acetyl-FHPG with 2-cyanoethyl N,N-diisopropylchlorophosphoramidite. Conversion to the intermediate dicyanoethylphosphoramidite and subsequent oxidation, deprotection and purification by HPLC on a SAX column afforded the desired compound.
17. Smee, D. F.; Boehme, R.; Chernow, M.; Binko, B. P.; Matthews, T. R. Biochem. Pharmacol. 1985, 34, 1049.